🇺🇸 FDA
Patent

US 7094411

Avirulent, immunogenic flavivirus chimeras

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 7094411 (Avirulent, immunogenic flavivirus chimeras) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Aug 22 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/53, A61K2039/70